Fundz

Annexon, Inc. reported raising $102 Million in an initial SEC Form D filing, from an offering of $102 Million

PUBLIC · ANNXJul 16, 2020

Amount Raised

$102 Million

$102 Million sold, per SEC Form D (first sale Jul 16, 2020)

Round Type

Venture

BrisbaneBiotechnology

Quick answer

Annexon raised $102 Million in a funding round, dated July 16, 2020. Annexon is based in Brisbane, California, United States.

How much did Annexon raise?
Annexon raised $102 Million in a funding round on July 16, 2020.
What does Annexon do?
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders..
Where is Annexon based and how big is it?
Annexon is based in Brisbane, California, United States. Fundz records about 119 employees.
Who are the decision-makers at Annexon?
Fundz holds 1 contact at Annexon, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Annexon that raised within 45 days of this round, from Fundz verified event records.

  • Prelude Therapeutics Inc raised $50M on August 28, 2020.
  • BirchBioMed Inc. raised $399K (Seed) on August 28, 2020.
  • Optimize Systems raised $15M on August 28, 2020.
  • Retrotope, Inc. raised $10M on August 28, 2020.
  • Genemod Corp raised $1M (Seed) on August 28, 2020.
  • Nanotech Energy, Inc. raised $28M on August 28, 2020.

Who to call at Annexon, and when

A new round usually means Annexon is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Annexon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Annexon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Annexon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Annexon

Location

1400 Sierra Point Parkway

Brisbane, California, United States

About

Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Annexon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMichael O., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Annexon's next move

See what Strategic adds

Annexon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.